Antengene Discovery Limited
1 clinical trials · Sponsor
◉ Watch Antengene Discovery Limited
| Record | Firm | Date |
|---|---|---|
| A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies (NCT05338346) | Antengene Discovery Limited | 2022-07-08 |
Track Antengene Discovery Limited automatically
Every clearance here is in the API, with alerts when new ones post.